In a study by Chang et al., activation of the Akt/PI3K pathway was linked to EMT and resistance to radiation [109], while knock-down of the CD44v6 variant in PC cell lines resulted in suppression of the Akt/PI3K pathway and sensitization of cancer cells to RT and chemotherapy [110]. This evidence concerns the gene AKT1 and cancer.